首页|微小RNA-324-5p在恶性肿瘤中的作用及其机制研究进展

微小RNA-324-5p在恶性肿瘤中的作用及其机制研究进展

扫码查看
微小RNA(miRNA)是一类长度约19~25个核苷酸的非编码单链RNA,可与靶基因3'非翻译区完全或不完全结合,抑制信使RNA翻译或促进其降解,发挥转录后调控作用。目前,已在多种恶性肿瘤中发现miR-324-5p的表达存在异常,并且在不同肿瘤中miR-324-5p通过作用于不同的靶基因调控着癌细胞的增殖、侵袭、转移和凋亡,表现出抑癌或促癌作用。该文对miR-324-5p在恶性肿瘤中的重要生物学功能和相关机制进行了综述,旨在为恶性肿瘤相关标志物和有效治疗靶点的开发提供新思路。
Research progress on the role and mechanism of microRNA-324-5p in malignant tumors
MicroRNAs(miRNA)is a class of non-coding single-stranded RNAs with length of about 19-25 nucleotides,which can completely or incompletely bind to the 3'ntranslated region(3'UTR)of the tar-get gene,inhibit the translation of messenger RNAs or promote its degradation,and exert post-transcriptional regulatory effects.At present,it has been found that the expression of miR-324-5p is abnormal in a variety of malignant tumors,and miR-324-5p regulates the proliferation,invasion,metastasis and apoptosis of cancer cells by acting on different target genes in different tumors,showing either oncogenic or pro-oncogenic effects.This article reviews the important biological functions and related mechanisms of miR-324-5p in malignant tumors,aiming to provide new ideas for the development of malignant tumor-related markers and effective therapeutic targets.

MicroRNA-324-5pMalignant tumorMechanismBiomarkersReview

杨清诚、刘晓华

展开 >

天津体育学院运动健康学院/天津市运动生理学与运动医学重点实验室,天津 301617

微小RNA-324-5p 恶性肿瘤 机制 生物标志物 综述

"十三五"国家重点研发计划项目

2017YFC0211603

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(16)